Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Cecile Blein"'
Autor:
Christos Chouaid, Jean Baptiste Assié, Pascal Andujar, Cecile Blein, Charlène Tournier, Alexandre Vainchtock, Arnaud Scherpereel, Isabelle Monnet, Jean Claude Pairon
Publikováno v:
Cancer Medicine, Vol 7, Iss 4, Pp 1102-1109 (2018)
Abstract This study was undertaken to determine the healthcare burden of malignant pleural mesothelioma (MPM) in France and to analyze its associations with socioeconomic deprivation, population density, and management outcomes. A national hospital d
Externí odkaz:
https://doaj.org/article/18eab90d15a3470197deb7c114050996
Autor:
Claire Leboucher, Cécile Blein, Valérie Machuron, Kelly Benyounes, Katell Le lay, Aurélie Millier, Romain Supiot, François Raffi
Publikováno v:
Journal of Market Access & Health Policy, Vol 11, Iss 1 (2023)
ABSTRACTBackground The economic consequences of the recent COVID-19 pandemic were substantial. However, direct medical costs in France have not been determined.Objective To describe patient characteristics, intensity of care, mortality, and direct me
Externí odkaz:
https://doaj.org/article/15497970cafa464081617ec53bd8ae24
Autor:
Aurélie Millier, Romain Supiot, Kelly Benyounes, Valérie Machuron, Katell Le Lay, Marine Sivignon, Claire Leboucher, Cécile Blein, François Raffi
Publikováno v:
Journal of Market Access & Health Policy, Vol 10, Iss 1 (2022)
Background Quantification of COVID-19 burden may be useful to support the future allocation of resources.Objective To evaluate the public health impact of COVID-19 in French ambulatory patients with at least one risk factor for severe disease.Study d
Externí odkaz:
https://doaj.org/article/127e431a65e14202bacc9742e0797ce4
Autor:
Arnaud Scherpereel, Isabelle Durand-Zaleski, François-Emery Cotté, Jérôme Fernandes, Didier Debieuvre, Cécile Blein, Anne-Françoise Gaudin, Charlène Tournier, Alexandre Vainchtock, Pierre Chauvin, Pierre-Jean Souquet, Virginie Westeel, Christos Chouaïd
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background Territorial differences in the access to innovative anticancer drugs have been reported from many countries. The objectives of this study were to evaluate access to innovative treatments for metastatic lung cancer in France, and t
Externí odkaz:
https://doaj.org/article/ad3734f99b804fe788808c1c80bb3664
Autor:
Christos Chouaïd, Didier Debieuvre, Isabelle Durand-Zaleski, Jérôme Fernandes, Arnaud Scherpereel, Virginie Westeel, Cécile Blein, Anne-Françoise Gaudin, Nicolas Ozan, Soline Leblanc, Alexandre Vainchtock, Pierre Chauvin, François-Emery Cotté, Pierre-Jean Souquet
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0182798 (2017)
The French healthcare system is a universal healthcare system with no financial barrier to access to health services and cancer drugs. The objective of the study is to investigate associations between, on the one hand, incidence and survival of patie
Externí odkaz:
https://doaj.org/article/4c7565b0d1ce481980192cfea894b4bf